Literature DB >> 16464399

Bone integrity and bone metastases in breast cancer.

Catherine Van Poznak1, Cristina Nadal.   

Abstract

Individuals with a history of early-stage breast cancer may be at increased risk of osteoporosis related to adjuvant therapy, and those with metastatic breast cancer may experience skeletal-related complications from the cancer affecting the bone. Maintaining bone strength is critical in the care of both early- and late-stage breast cancer patients because fractures are associated with morbidity and mortality. This article reviews the maintenance of bone integrity in women with breast cancer.

Entities:  

Mesh：

Year:  2006        PMID： 16464399     DOI： 10.1007/s11912-006-0005-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  38 in total

Review 1.  Mechanisms of bone metastasis.

Authors:  G David Roodman
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

Review 2.  Clinical management of osteoporosis in women with a history of breast carcinoma.

Authors:  Catherine Van Poznak; Nicholas P Sauter
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

Review 3.  Management of bone metastases in breast cancer.

Authors:  Allan Lipton
Journal:  Curr Treat Options Oncol       Date:  2005-03

4.  Daily and cyclic parathyroid hormone in women receiving alendronate.

Authors:  Felicia Cosman; Jeri Nieves; Marsha Zion; Lillian Woelfert; Marjorie Luckey; Robert Lindsay
Journal:  N Engl J Med       Date:  2005-08-11       Impact factor: 91.245

5.  Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.

Authors:  Zhao Chen; Michael Maricic; Tamsen L Bassford; Mary Pettinger; Cheryl Ritenbaugh; Ana Maria Lopez; David H Barad; Margery Gass; Meryl S Leboff
Journal:  Arch Intern Med       Date:  2005-03-14

Review 6.  Osteoporosis in breast and prostate cancer survivors.

Authors:  Ana O Hoff; Robert F Gagel
Journal:  Oncology (Williston Park)       Date:  2005-04       Impact factor: 2.990

7.  An approach to identifying osteopenic women at increased short-term risk of fracture.

Authors:  Paul D Miller; Suna Barlas; Susan K Brenneman; Thomas A Abbott; Ya-Ting Chen; Elizabeth Barrett-Connor; Ethel S Siris
Journal:  Arch Intern Med       Date:  2004-05-24

8.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

9.  Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.

Authors:  J-J Body; I J Diel; M R Lichinitser; E D Kreuser; W Dornoff; V A Gorbunova; M Budde; B Bergström
Journal:  Ann Oncol       Date:  2003-09       Impact factor: 32.976

Review 10.  American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Authors:  Eric P Winer; Clifford Hudis; Harold J Burstein; Antonio C Wolff; Kathleen I Pritchard; James N Ingle; Rowan T Chlebowski; Richard Gelber; Stephan B Edge; Julie Gralow; Melody A Cobleigh; Eleftherios P Mamounas; Lori J Goldstein; Timothy J Whelan; Trevor J Powles; John Bryant; Cheryl Perkins; Judy Perotti; Susan Braun; Amy S Langer; George P Browman; Mark R Somerfield
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544
View more
  1 in total

Review 1.  Effect of bisphosphonates on pain and quality of life in patients with bone metastases.

Authors:  Luis Costa; Pierre P Major
Journal:  Nat Clin Pract Oncol       Date:  2009-02-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.